NCT07171710View on ClinicalTrials.gov

Efficacy of 0.05% Cyclosporine A Eye Drops Combined With Absorbable Tear Duct Plugs in the Treatment of Dry Eye in Sjögren's Syndrom

NAEnrolling by invitationINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

March 1, 2026

Study Completion Date

March 31, 2026

Conditions
Dry Eye Disease
Interventions
DRUG

0.05% Cyclosporine Eye Drops

Cyclosporin A 0.05% eye drops were administered twice daily to both eyes

DEVICE

Smart plug absorbable lacrimal duct plugs

The lacrimal duct embolization implant is performed by partially sealing the tear discharge duct to increase the lubrication of natural tears on the eye surface.

Trial Locations (1)

Unknown

Tianjin Eye Hospital, Tianjin

All Listed Sponsors
lead

Tianjin Eye Hospital

OTHER